Uemura Osamu, Iwata Naoyuki, Nagai Takuhito, Yamakawa Satoshi, Hibino Satoshi, Yamamoto Masaki, Nakano Masaru, Tanaka Kazuki
Department of Pediatric Nephrology, Aichi Children's Health and Medical Center, 426 7-chome, Morioka-cho, Obu, Aichi, 474-8710, Japan.
Department of Clinical Medicine, Japanese Red Cross Toyota College of Nursing, 12-33 Nanamagari, Hakusan-cho, Toyota, Aichi, 471-8565, Japan.
CEN Case Rep. 2018 May;7(1):169-173. doi: 10.1007/s13730-018-0320-7. Epub 2018 Feb 28.
To determine the optimal method of evaluating kidney function in patients with thyroid dysfunction, this study compared the estimated glomerular filtration rate derived from serum creatinine, cystatin C, or β2-microglobulin with inulin or creatinine clearance in two pediatric patients, one with hypothyroidism and the other with hyperthyroidism. It was observed that the kidney function decreased in a hypothyroid child and enhanced in a hyperthyroid child, with their kidney function becoming normalized by treatment with drugs, which normalized their thyroid function. Kidney function cannot be accurately evaluated using cystatin C-based or β2-microglobulin-based estimated glomerular filtration rate in patients with thyroid dysfunction, as these tests overestimated glomerular filtration rate in a patient with hypothyroidism and underestimated glomerular filtration rate in a patient with hyperthyroidism, perhaps through a metabolic rate-mediated mechanism. In both our patients, 24-h urinary creatinine secretion was identical before and after treatment, suggesting that creatinine production is not altered in patients with thyroid dysfunction. Therefore, kidney function in patients with thyroid dysfunction should be evaluated using creatinine-based estimated glomerular filtration rate.
为了确定评估甲状腺功能障碍患者肾功能的最佳方法,本研究在两名儿科患者中比较了根据血清肌酐、胱抑素C或β2-微球蛋白得出的估计肾小球滤过率与菊粉或肌酐清除率,其中一名患者患有甲状腺功能减退症,另一名患有甲状腺功能亢进症。观察到甲状腺功能减退症患儿的肾功能下降,甲状腺功能亢进症患儿的肾功能增强,通过药物治疗使他们的甲状腺功能恢复正常后,其肾功能也恢复正常。在甲状腺功能障碍患者中,使用基于胱抑素C或β2-微球蛋白的估计肾小球滤过率无法准确评估肾功能,因为这些检测在甲状腺功能减退症患者中高估了肾小球滤过率,而在甲状腺功能亢进症患者中低估了肾小球滤过率,这可能是通过代谢率介导的机制。在我们的两名患者中,治疗前后24小时尿肌酐分泌量相同,这表明甲状腺功能障碍患者的肌酐生成没有改变。因此,甲状腺功能障碍患者的肾功能应使用基于肌酐的估计肾小球滤过率进行评估。